Atlas Trials

The Safety, Tolerability, and Pharmacokinetic Study of SC1011 in Healthy Subjects.

Clinical trial NCT06160440 · COMPLETED

Trial details

NCT number
NCT06160440
Sponsor
Guangzhou JOYO Pharma Co., Ltd
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Diopathic Pulmonary FibrosisPulmonary Fibrosis
Start date
2021-06-03
Primary completion
2021-09-23
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.